Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
about
Early lenalidomide treatment for low and intermediate-1 International Prognostic Scoring System risk myelodysplastic syndromes with del(5q) before transfusion dependence.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 September 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Early lenalidomide treatment f ...... odysplastic syndromes with del
@nl
Early lenalidomide treatment f ...... before transfusion dependence.
@en
type
label
Early lenalidomide treatment f ...... odysplastic syndromes with del
@nl
Early lenalidomide treatment f ...... before transfusion dependence.
@en
prefLabel
Early lenalidomide treatment f ...... odysplastic syndromes with del
@nl
Early lenalidomide treatment f ...... before transfusion dependence.
@en
P2093
P2860
P50
P356
P1433
P1476
Early lenalidomide treatment f ...... before transfusion dependence
@en
P2093
Alessandra Ricco
Andrea Kündgen
Antonella Poloni
Antonio Volpe
Caterina Alati
Enrico Balleari
Esther N Oliva
Francesca Ronco
Grazia Sanpaolo
Irene Santacaterina
P2860
P304
P356
10.1002/CAM4.523
P407
P577
2015-09-17T00:00:00Z